Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations

scientific article published on April 1, 1979

Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/J.1552-4604.1979.TB01657.X
P953full work available at URLhttp://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1979.tb01657.x/fullpdf
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1979.tb01657.x
P698PubMed publication ID374429

P2093author name stringV. DeQuattro
V. M. Campese
D. Stein
P2860cites workClinical and haemodynamic effects of minoxidil in refractory hypertensionQ28328983
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemideQ28339392
Minoxidil in severe hypertension: value when conventional drugs have failedQ28339588
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man.Q34463968
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activityQ34473162
Treatment of severe hypertension with minoxidilQ39064011
Altered renin release and propranolol potentiation of vasodilatory drug hypotensionQ40317304
Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilatorQ40329388
The physiological basis of thirstQ40564696
Effect of minoxidil on blood pressure and hemodynamics in severe hypertensionQ40770064
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.Q53829232
Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.Q54175978
The effects of minoxidil on pulmonary and systemic hemodynamics in hypertensive man.Q54600664
Severe hypertension. Treatment with minoxidil.Q54624274
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.Q55061463
Vasodilating drugs: contrasting haemodynamic effectsQ66864186
The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patientsQ66864188
Treatment of severe hypertension with minoxidil and its effects on systemic and pulmonary haemodynamicsQ66864190
Minoxidil Therapy in Refractory Hypertension Analysis of 155 PatientsQ66888516
Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failureQ67493931
Minoxidil treatment of severe hypertensionQ67509692
Effects of saline and albumin on plasma and urinary catecholamines in dogsQ67554216
Increased pulmonary vascular resistance with systemic hypertension. Effect of minoxidil and other antihypertensive agentsQ67584182
Minoxidil--an alternative to nephrectomy for refractory hypertensionQ68510756
Pharmacologic properties of minoxidil: a new hypotensive agentQ69381505
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugsQ69481858
HirsutismQ69878772
Pharmacokinetic studies of minoxidilQ70374165
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)231-241
P577publication date1979-04-01
P1433published inThe Journal of Clinical PharmacologyQ7743562
P1476titleTreatment of Severe Hypertension with Minoxidil: Advantages and Limitations
P478volume19

Reverse relations

cites work (P2860)
Q83227530A model of orthostatic hypotension in the conscious monkey using lower body negative pressure
Q70940641Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713
Q47913024Clinical pharmacokinetics of vasodilators. Part I.
Q73480775Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels*
Q34287794Direct vasodilators and their role in hypertension management: minoxidil
Q34024129Evolution of drugs that preserve renal function
Q51171680Management of hypertension in hemodialysis patients.
Q40319953Minoxidil: a review of its pharmacological properties and therapeutic use.
Q35767515Minoxidil: an underused vasodilator for resistant or severe hypertension
Q36908011The management of hypertension in hemodialysis and CAPD patients.
Q39285079The role of stress and the sympathetic nervous system in hypertension and ischemic heart disease: advantages of therapy with beta-receptor blockers
Q69909244Topical minoxidil in early male pattern baldness
Q46519410Vasodilators and inhibitors of angiotensin converting enzyme in resistant hypertension
Q71407315[Comparison of oral diazoxide and minoxidil in refractory hypertension]